Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study

Table 1

Pathology results by fecal immunochemical test value.

	10–14.9 μg/g; (50–74 ng/mL); (/%)	15–19.9 μg/g; (75–99 ng/mL); (/%)	20–39.9 μg/g; (100–199 ng/mL); (/%)	40–99.9 μg/g; (200–499 ng/mL); (/%)	≥100 μg/g; (≥500 ng/mL); (/%)	Total; (/%)
CRC	40 (0.6)	21 (0.7)	44 (1.1)	102 (3.2)	242 (8.4)	449 (2.3)
HRA	836 (12.6)	464 (15.8)	801 (19.8)	802 (25.4)	1109 (38.4)	4012 (20.4)
MLRA	401 (6.0)	188 (6.4)	263 (6.5)	189 (6.0)	132 (4.6)	1173 (6.0)
LRA	1857 (28.0)	813 (27.7)	1112 (27.5)	773 (24.5)	474 (16.4)	5029 (25.6)
No neoplasia	3507 (52.8)	1444 (49.3)	1824 (45.1)	1292 (40.9)	930 (32.2)	8997 (45.8)
Total	6641	2930	4044	3158	2887	19660

CRC, colorectal cancer; HRA, high-risk adenoma; LRA, low-risk adenoma; MLRA, multiple low-risk adenomas.